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The extracellular matrix plays a key role in stem cell
maintenance, expansion, and differentiation. Lami-
nin, a basement membrane protein, is a widely
used substrate for cell culture including the growth
of human induced pluripotent stem cells (hiPSCs).
Here, we show that different isoforms of laminin
lead to the selective differentiation of hiPSCs into
different eye-like tissues. Specifically, the 211 iso-
form of the E8 fragment of laminin (LN211E8) pro-
motes differentiation into neural crest cells via Wnt
activation, whereas LN332E8 promotes differentia-
tion into corneal epithelial cells. The immunohisto-
chemical distributions of these laminin isoforms in
the developing mouse eye mirrors the hiPSC type
that was induced in vitro. Moreover, LN511E8 en-
ables generation of dense hiPSC colonies due to
actomyosin contraction, which in turn led to cell den-
sity-dependent YAP inactivation and subsequent
retinal differentiation in colony centers. Thus, distinct
laminin isoforms determine the fate of expanded
hiPSCs into eye-like tissues.INTRODUCTION
Human pluripotent stem cells (hPSCs), including human embry-
onic stem cells (hESCs) and human induced pluripotent stem
cells (hiPSCs), can undergo long-term expansion in culture and
be induced to differentiate into cells of all three germ layers (Ta-
kahashi et al., 2007; Thomson et al., 1998; Yu et al., 2007). As
such, they have considerable value for developmental studies,
drug screening, and research in regenerative medicine. Soluble
components in the culture medium, including growth factors,
provide cues for hPSC fate specification, as do culture sub-
strates and their coating with extracellular matrix (ECM) proteins1668 Cell Reports 25, 1668–1679, November 6, 2018 ª 2018 The Au
This is an open access article under the CC BY-NC-ND license (http://(Czyz and Wobus, 2001; Hayashi and Furue, 2016). The ECM
plays a fundamental role in the maintenance of the stem cell
niche, as it regulates the proliferation and differentiation of
stem cells (Gattazzo et al., 2014). The ECM protein laminin, a
major component of basement membranes, is a heterotrimeric
protein assembled from a (a1–5), b (b1–3), and g (g1–3) chain
subunits, the composition of which is reflected in the isoform
nomenclature (Aumailley et al., 2005). The expression of laminin
is spatiotemporally regulated, especially during development
(Miner et al., 1997; Nguyen and Senior, 2006), with several lam-
inin isoforms able to support hPSC proliferation in undifferenti-
ated states (Miyazaki et al., 2008; Rodin et al., 2010, 2014; Xu
et al., 2001). Truncated versions of the protein—the laminin E8
fragments (LNE8)—permit robust proliferation of hPSCs (Miya-
zaki et al., 2012), while other isoforms are known to be effective
in the long-term expansion or generation of specific somatic cell
types from hPSCs (Fusaoka-Nishioka et al., 2011; Kanninen
et al., 2016; Ohta et al., 2016; Takayama et al., 2013, 2016).
Using E8 fragments of laminin-511 (LN511E8), we have gener-
ated hiPSC-derived colonies comprising four concentric cell
zones, the emergence of which displays some similarities with
ocular development (Hayashi et al., 2016, 2017). We termed
these types of colonies ‘‘self-formed ectodermal autonomous
multi-zones’’ (SEAMs) of eye-like cells. SEAMs grown on
LN511E8 contain cells with the immunostaining characteristics
of different ocular lineages, and include retinal-like cells, lens-
like cells, and cells reminiscent of ocular surface epithelial cells.
Here, we differentiated hiPSCs on a range of laminin isoforms
and show that the nature of the laminin isoform is instrumental
in the determination of cell fate.RESULTS
Laminin Isoform-Dependent Autonomous
Differentiation of hiPSCs
When coated onto culture plates, five isoforms of LNE8 (111,
211, 332, 411, and 511) were each able to support autonomous
differentiation of hiPSC clones 201B7 and 1383D2. Although cellthors.
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Ocular Cell Differentiation from hiPSCs on Different Laminin Isoforms
(A) Schematic representation of the ocular cell differentiation protocol on laminin isoforms.
(B) SEAM structure on LN511E8.
(C) Phase contrast images of hiPSCs grown on different laminin isoforms. Scale bars: 200 mm. The numbers indicate SEAM zones to which the differentiated cells
correspond.
(D) Immunostaining of cells differentiated on different laminin isoforms: p75 (green) and SOX10 (red) were stained after 2 weeks of differentiation, TUBB3 (green)
after 8 weeks of differentiation, and E-cadherin (green) and VSX2 (red) after 10 weeks of differentiation. Nuclei, blue. Scale bars: 100 mm.
(E) Gene expression analysis in cells differentiated on each laminin isoform. Neural, neural crest, retinal, and epithelial markers were analyzed at 4, 4, 4, and
12 weeks of differentiation, respectively. The results are presented as means ± SEM; n = 5 cell samples of three independent experiments for 111, 332, 411, and
511; n = 4 cell samples of three independent experiments for 211 (neural, neural crest, and retinal markers); and n = 3 cell samples of two independent ex-
periments for all isoforms (epithelial markers). *p < 0.05, **p < 0.01, and ***p < 0.001.
(legend continued on next page)
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Table 1. An Indication of Zonal Formation on Different Laminin
Isoforms andDistributions of Laminin Isoforms duringMouse Eye
Development
Ocular Cell Differentiation from hiPSCsa
Cell type Zone
E8 Fragments of Laminin
111 211 332 411 511
Neural
crest
(2–4w)
2 + ++ + + +
Retina 2    + +
Epithelium 3  + ++  +
Mouse Embryonic Eye (E15.5)b
Cell type Laminin Expression
a1 a2 a3 a4 a5
Neural
crest-
derived
+ +  + +
(Chr,
Scl)
(CS, CEnd,
Chr, Scl)
(CEnd,
Chr, Scl,
Vit)
(Scl)
Retina +   + +
(NR) (NR) (RPE)
Epithelium + + +  +
(LE) (Epi) (Epi,
CEpi)
(Epi, CEpi,
LE)
aAn indication of zonal formation on different laminin isoforms. (++), (+),
and () indicate larger, equivalent, or lower amounts of zone formation
than that observed on LN511E8, respectively.
bEpi, epidermis; CEpi, corneal epithelium; CS, corneal stroma; CEnd,
corneal endothelium; LE, lens epithelium; Chr, Choroid; Scl, Sclera; Vit,
Vitreous; NR, neuroretina; RPE, retinal pigment epithelium.viability varied by isoform, in all cases cells adhered, proliferated,
and expressed pluripotency markers (Figures 1A and S1A–S1D).
The typical four-zone SEAM structure seen previously, however,
was only generated in the presence of LN511E8, the isoform em-
ployed in our published experiments (Figure 1B) (Hayashi et al.,
2016, 2017). The other four isoforms, LN111E8, LN211E8,
LN332E8, and LN411E8, supported the formation of SEAMs
with distinct structural configurations. As identified by their
morphology under phase contrast microscopy, hiPSCs
expanded on LN111E8 tended to aggregate and stratify and
were composed mainly of zone 1 cells along with a minor
component of zone 3/4 cells. When grown on LN211E8, the
differentiated cells resembled those from LN511E8-cultured
zone 1. Cells differentiated on LN332E8 gave rise exclusively
to cells of SEAM zones 3 and 4, which display an epithelial-like
phenotype. Cells differentiated on LN411E8 resembled those
from LN511E8-cultured zones 1 and 2 (Figure 1C).
Analysis of eye development-related markers revealed that
LN111E8 and LN211E8 led to the appearance of TUBB3+
neuronal fibers. Moreover, LN211E8 promoted differentiation
of p75+/SOX10+ presumed neural crest cells (Kim et al., 2003).(F) Immunostaining for laminin a1–5 (green) during mouse eye development at E1
100 mm (in anterior and posterior panels) and 20 mm (in cornea panels). Epi, epide
corneal endothelium; Chr, choroid; Scl, sclera; Vit, Vitreous; NR, neuroretina; RP
(G) Schematic of mouse embryonic eye (E15.5) and expression of laminin a chai
1670 Cell Reports 25, 1668–1679, November 6, 2018We also confirmed that LN211E8 promoted differentiation of
p75+/ITGA4+ cells (Bixby et al., 2002;Morrison et al., 2000; Pinco
et al., 2001) by flow cytometry (Figure S2A). On the other hand,
numerous E-cadherin+ epithelial cells were present in colonies
grown on LN332E8. When cultured on LN411E8, TUBB3+ cells,
which were confined to zone 2 in LN511E8-derived SEAMs,
expanded more peripherally. Neuroretinal marker VSX2+ cells
(Meyer et al., 2009) were induced on both LN411E8- and
LN511E8-coated dishes (Figure 1D). The gene expression levels
of the neural marker SOX2 and neural crest marker SOX10 were
relatively high in cells differentiated on LN211E8. In agreement
with immunostaining results, the expression levels of retina-
related genes, such as RAX and VSX2, were elevated in cells
differentiated on LN411E8 and LN511E8, while those of the
epithelial genes DN-p63 and E-cadherinwere high in cells differ-
entiated on LN332E8 (Figures 1E and S2B).
The distribution of laminin in developing mammalian eyes has
been the subject of previous investigations (Bystro¨m et al., 2006;
Qin et al., 1997) and was examined in detail here. At embryonic
day 15.5 (E15.5) in the mouse, expression of isoform a1 was
confirmed in the lens epithelium, neuro-retina, choroid, and
sclera. Isoform a2 was expressed in neural crest-derived tissues
such as the corneal stroma, corneal endothelium, choroid, and
sclera, while a3 was expressed in stratified epithelial cells of
the epidermis and corneal epithelium. a4 was expressed in
corneal endothelium, vitreous, neuroretina, choroid, and sclera.
a5 was expressed in a range of epithelial tissues, including the
epidermis, corneal epithelium, lens epithelium, retinal pigment
epithelium (RPE), and sclera (Figures 1F and 1G). Collectively,
these results indicated that distinct laminin isoforms differentially
affect autonomous ectoderm cell differentiation in hiPSC culture.
Moreover, it appears as though the laminin isoform associated
with various ocular tissues in the developing eye in vivo can
be employed in vitro to direct differentiation into this type of
cell (Table 1).
Use of LN332E8 for Corneal Epithelial Sheet Fabrication
from hiPSCs
Based on the results described above, we hypothesized that
LN332E8 would be able to effectively facilitate the genera-
tion of hiPSC-derived corneal epithelial cells (iCECs). To
investigate this, after 10–12 weeks of differentiation culture of
hiPSCs on each laminin isoform, the percentage of SSEA-4+/
ITGB4+/CD200 cells (i.e., the iCEC fraction) was evaluated by
flow cytometry. This revealed that hiPSCs differentiated on
LN332E8 possessed the highest proportion of iCECs (Figures
2A and 2B). Moreover, iCECs differentiated on this isoform
(i.e., 332-iCECs) exhibited a colony-forming efficiency equivalent
to that of iCECs differentiated on LN511E8 (511-iCECs) (Figures
2C–2E). The 332-iCECs and 511-iCECs, when expanded,
formed a cell sheet that expressed the corneal epithelial markers
PAX6, keratin (KRT) 12, p63, and MUC16 (Figure 2F). qRT-PCR
analysis revealed no significant differences between expanded5.5; similar data (not shown) were obtained at E18.5. Nuclei, blue. Scale bars:
rmis; LE, lens epithelium; CEpi, corneal epithelium; CS, corneal stroma; CEnd,
E, retinal pigment epithelium.
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Figure 2. LN332E8 for iCEC Fabrication
(A) Flow cytometry analysis for SSEA-4+/ITGB4+/CD200 cells after 10–12 weeks of differentiation culture. Live cells were analyzed using antibodies specific for
SSEA-4 and CD200 (upper panel). CD200 cells were analyzed using antibodies specific to SSEA-4 and ITGB4 (lower panel).
(B) Quantification of SSEA-4+/ITGB4+/CD200 cells in differentiated 201B7 and 1383D2 cells (mean ± SEM; n = 13 for 111 and 411, n = 9 cell samples for 211,
n = 20 cell samples for 332 and 511 [201B7], 13 independent experiments; n = 4 samples of two independent experiments for all isoforms [1383D2]).
(C) Schematic of differentiation protocol.
(D and E) Colony-forming assays for 332-iCECs and 511-iCECs. Fixed colonies were stained with Rhodamine B (D) and colony-forming efficiency was calculated
(E). The results are presented as means ± SEM; n = 7 cell samples of two independent experiments. Scale bar: 5 mm.
(F) Immunostaining for PAX6 (green), MUC16 (red), KRT12 (green), and p63 (red) in 332-iCEC and 511-iCEC sheets at 12 weeks. Nuclei, blue. Scale bar: 50 mm.
(G) Schematic of differentiation protocol.
(H) Gene expression analysis for LIN28A in differentiated hiPSCs on LN332E8 and LN511E8 at 6 weeks of differentiation. The results are presented as means ±
SEM; n = 6 cell samples of three independent experiments; ***p < 0.001.
(I) Flow cytometry graphs for SSEA-4+/ITGB4+/CD200 cells after 6 weeks of differentiation culture (mean values from three independent experiments).
(J) Immunostaining for PAX6 (green), MUC16 (red), KRT12 (green), and p63 (red) in stratified 332-iCEC and 511-iCEC sheets at 6 weeks. Nuclei, blue. Scale
bar: 50 mm.332-iCEC and 511-iCEC sheets in the expression levels of
genes encoding corneal and non-corneal epithelial markers
(Figure S3A).
Based on the heightened efficiency of the LN332E8 substrate
in the generation of iCEC sheets, we investigated the possibilityof using an abridged (i.e., 6-week) cultivation period (Figure 2G).
This revealed that cultivation on LN332E8 resulted in reduced
expression of LIN28A, a marker of residual undifferentiated cells,
compared to the expression in cells cultured on LN511E8 (Fig-
ure 2H). Cells grown on LN332E8 also produced higher numbersCell Reports 25, 1668–1679, November 6, 2018 1671
of SSEA-4+/ITGB4+/CD200 cells than those cultivated on
LN511E8 (Figure 2I), while the 332-iCEC-generated sheet ex-
hibited strong expression of corneal epithelial markers. The cell
sheet prepared using 511-iCECs, in contrast, was inadequate
in this regard (Figure 2J), indicating that LN332E8 is effective in
enhancing the yield of iCECs and shortening the differentiation
period for iCEC sheet preparation. It was also notable that
SEAM zone 1 cells (corresponding to neural cells) proliferate
slowly when cultured on LN332E8 and easily detach from the
substrate after long-term differentiation (Figures S3B–S3D).
Wnt Activation on LN211E8 during Neural Crest
Differentiation
Microarray analysis, hierarchical clustering, and principal-
component analysis of differentially expressed genes in hiPSCs
during the early stage (i.e., day 3) of differentiation on each lam-
inin isoform showed that cultivation on LN211E8, LN332E8, and
LN511E8 resulted in marked changes in gene expression (Fig-
ures 3A–3D, S4A, and S4B). We further analyzed differentially
upregulated genes in cells on each isoform using WikiPathways
(Table S1). The number of pathways with a p value less than 0.05
was greatest on 211. In agreement with the results shown in Fig-
ure 2, in the 211 pathway list, the pathwaywith the lowest p value
was ‘‘neural crest differentiation’’ (p = 1.05 3 108) (Table S1).
LN211E8 induced neural crest development-related genes
even at this early phase of differentiation (Figure 3E). Further-
more, cells differentiated on LN211E8 expressed PITX2 and
FOXC1, craniofacial neural crest markers (Figure 3F). We also
found that the ‘‘Wnt signaling pathway’’ was enriched (fifth lower,
p = 5.87 3 104) in upregulated genes in cells differentiated on
LN211E8 (Table S1). Figures 3G and S4C show theWnt signaling
pathway-related genes. We confirmed that expression of the
Wnt/b-catenin target genes AXIN2 and LEF1 was upregulated
in the cells cultured on LN211E8 (Figure 3H).
Wnt activation is known to elicit the differentiation of hPSCs
into neural crest cells (Leung et al., 2016; Menendez et al.,
2011). To examine this, we treated hiPSCs grown on LN211E8
or LN511E8 with IWP2, a Wnt signaling inhibitor, or CHIR99021,
a Wnt signaling agonist, for the first 3 days of differentiation (Fig-
ure 3I). After 2 weeks of differentiation, 49% and 0.39% of the
cells grown on LN211E8 and LN511E8, respectively, were
p75+/ITGA4+ presumed neural crest cells. Notably, treatment
with the Wnt inhibitor IWP2 decreased the proportion of p75+/
ITGA4+ cells on LN211E8 by 12%. In contrast, the Wnt activator
CHIR99021 promoted the emergence of p75+/ITGA4+ cells on
LN511E8 by 7.6% (Figure 3J). Immunostaining analysis detected
a decrease in p75+/SOX10+ cells on LN211E8 following IWP2
treatment and an increase in these cells on LN511E8 after
CHIR99021 treatment (Figure 3K). These findings indicate that
LN211E8-activated Wnt signaling is necessary for the commit-
ment of hPSCs to become neural crest cells.
Cell Density-Dependent Inactivation of YAP within
hiPSC Colonies on LN511E8
When examining hiPSCs using time-lapse microscopy, it
became evident that hiPSC colony formation on LN332E8
occurred via cells proliferating and migrating outward, whereas
cells on LN511E8 proliferated with little radial movement (Fig-1672 Cell Reports 25, 1668–1679, November 6, 2018ure 4A). Colonies grown on LN332E8 grew to a larger final size
than those grown on LN511E8, but at a more gradual pace (Fig-
ures 4B and 4C). The relative lack of cell movement in LN511E8-
expanded hiPSC colonies resulted in a comparatively high cell
density toward the centers of these colonies (Figures 4D and
4E). In these cell-dense central regions of LN511E8-expanded
colonies, N-cadherin was highly expressed after 3 days of differ-
entiation (Figure 4F), suggesting that cell density may be instru-
mental in neuroectoderm differentiation at the center of the
colonies cultured on this isoform. Moreover, microarray analysis
suggested that genes involved in the specialization of the retina,
such as RAX, PAX6, LHX2, and MAB21L2 (Bailey et al., 2004),
were upregulated in hiPSCs grown on LN511E8 compared to
those cultured on LN332E8 (Figure S4D).
YAP is a transcription factor that senses cell density and reg-
ulates neuronal specifications (Hsiao et al., 2016). Here, we
uncovered a correlation between the expression levels of cyto-
plasmic YAP and PAX6 in differentiated hiPSCs grown on both
LN332E8 and LN511E8 at day 3 of differentiation. Cytoplasmic
YAP localization and PAX6 expression were higher in the cells
grown on LN511E8 than in those grown on LN332E8 (Figure 4G).
Cell fractionation followed by western blotting also showed that
the proportion of nuclear YAP was higher in cells cultivated on
LN332E than in cells grown on LN511E8 (Figure 4H). The expres-
sion levels of YAP target genes, including CTGF and CYR61,
were downregulated in hiPSCs cultured on LN511E8-coated
dishes compared to levels observed in cells cultured on
LN332E8-coated dishes after 10 days in iPSC culture (Figure 4I).
To ascertain whether cell density causes YAP inactivation, we
examined the relationship between hiPSC density and neuroec-
toderm differentiation. This revealed that YAP inactivation and
neuroectoderm differentiation were promoted by increasing
cell seeding numbers (Figure S5A) and the duration of the colony
forming period (Figures 4J–4L and S5B). It also became
apparent that the levels of F-actin, which are known to affect
YAP activity (Sansores-Garcia et al., 2011), did not differ be-
tween cells cultured on LN332E8 or LN511E8 (Figure S5C). To
investigate whether YAP activity regulates differentiation, we
treated hiPSCs with verteporfin (VP), a suppressor of the YAP-
TEAD interaction (Liu-Chittenden et al., 2012) and found that it
resulted in enhanced expression of PAX6 and RAX (Figures 4M
and S5D). Similarly, PAX6 and RAX expression was increased
in the presence of latrunculin A (Lat-A), an inhibitor of F-actin
that is necessary for YAP nuclear localization (Figures S5E–
S5G). Together, these results clearly demonstrate that culturing
hiPSCs on LN511E8 leads to YAP inactivation and neuroecto-
derm differentiation at the center of hiPSC-derived colonies
and that high cell density is a key factor in this process.
Actomyosin Contraction for Dense hiPSC Colony
Formation on LN511E8
Phosphorylated myosin light chain (p-MLC), a contractile force
marker, was strongly localized at the periphery of hiPSC col-
onies, especially those grown on LN511E8 (Figure 5A). Western
blot analysis showed that MLC phosphorylation was stimulated
in hiPSCs cultivated on LN511E8, but inhibited in those culti-
vated on LN211E8. On day 10, p-MLC was also observed in
hiPSC colonies grown on LN332E8. In contrast, cells cultivated
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Figure 3. LN211E8 Activates Wnt Signaling and Neural Crest Differentiation in hiPSCs
(A) Schematic of differentiation protocol.
(B) Hierarchical cluster analysis of differentially expressed genes using Euclidean distance and complete linkage metric.
(C) Principal-component analysis of differentially expressed genes.
(D) The number of upregulated and downregulated genes in cells differentiated on each isoform.
(E) Heatmap of gene expression levels for neural crest development-related genes in cells differentiated on different laminin isoforms.
(F) Immunostaining for PITX2 (green) and FOXC1 (red) in cells differentiated on LN211E8 at 4 weeks of differentiation. Nuclei, blue. Scale bar: 100 mm.
(G) Hierarchical cluster analysis of Wnt signaling pathway-related genes in cells differentiated on different laminin isoforms.
(H) Gene expression analysis of Wnt/b-catenin target genes in cells differentiated on LN211E8, LN332E8, and LN511E8 after 3-day differentiation culture. The
results are presented as means ± SEM; n = 5 cell samples of two independent experiments; *p < 0.05.
(I) Schematic of differentiation protocol. ICC, immunocytochemistry; NC, neural crest.
(J) Flow cytometry graph for p75 and ITGA4 in cells differentiated on LN211E8 with or without IWP2 (5 mM) and on LN511E8 with or without CHIR99021 (10 mM)
(mean values from three independent experiments).
(K) Immunostaining for p75 (green) and SOX10 (red) in cells differentiated on LN211E8 with or without IWP2 (5 mM) and on LN511E8 with or without CHIR99021
(10 mM). The arrows indicate p75+/SOX10+ cells. Nuclei, blue. Scale bar: 100 mm.on LN211E8 exhibited enhanced phosphorylation of vinculin,
which recognizes cell-cell but not cell-matrix adhesions (Bays
et al., 2014), as determined using antibody Y822 (Figure 5B).
Thus, it was suggested that cell-cell interactions and cell-matrixinteractions predominate on LN211E8 and LN511E8, respec-
tively (Figure 5C). Based on this reasoning, we tested the prem-
ise that the coating concentration of LN511E8 would affect
iPSC behavior and subsequent differentiation. Indeed, whenCell Reports 25, 1668–1679, November 6, 2018 1673
Figure 4. Cell Density-Dependent YAP Inactivation within hiPSC Colonies on LN511E8
(A and B) Time-lapse microscopy of hiPSCs on LN332E8 and LN511E8 at early stage (A) and late stage (B) of iPSC culture. Scale bars: 100 mm (A) and 300 mm (B).
In (A), the observation starting point (0 hr) was after 2 days in culture.
(C) Diameters of hiPSC colonies at day 10 of iPSC culture are presented as means ± SEM; n = 10 colonies; ***p < 0.001.
(D) Cells at the center and periphery of hiPSC colonies on LN332E8 and LN511E8. Nuclei, red. Scale bars: 50 mm (upper) and 20 mm (lower magnified panels).
(E) Quantification of cell densities are shown as means ± SEM; n = 10 colonies; *p < 0.05, **p < 0.01, and ***p < 0.001.
(legend continued on next page)
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the coating concentration of LN511E8 was increased, focal
adhesions recognized by vinculin were formed, and the shape
of the colonies became more rounded (Figure 5D). Furthermore,
p-MLC levels at the periphery of hiPSC colonies, PAX6 expres-
sion, and colony compaction were also found to positively corre-
late with LN511E8 coating concentrations (Figures 5E–5G and
S6). These results suggest that LN511E8 promotes actomyosin
contraction through the strength and frequency of adhesion
within hiPSC colonies (Figure 5H). Indeed, treatment with bleb-
bistatin, a myosin heavy chain ATPase inhibitor (Straight et al.,
2003), abolished hiPSC compaction during colony formation
and resulted in a reduced cell density (Figures 5I–5L). This led
to decreased PAX6 expression and YAP nuclear localization
(Figure 5M), as confirmed by qRT-PCR analysis, which revealed
a reduction in PAX6 and RAX expression (and an increase in
CTGF andCYR61 expression) following pre-treatment with bleb-
bistatin (Figure 5N). Cumulative evidence thus points to the acto-
myosin contractile force as a driver of the formation of densely
packed central regions of hiPSC colonies grown on LN511E8,
which, in turn, likely promotes YAP inactivation and subsequent
neuroectoderm differentiation.
DISCUSSION
The microenvironment surrounding stem cells, including the
identity of ECM proteins and growth factors and the physical
characteristics of the supporting tissue, are all important
for determining stem cell fates (Engler et al., 2006; Kundu
and Putnam, 2006; Pryzhkova et al., 2014). We previously
developed the ‘‘SEAM method’’ using LN511E8, which can
preferentially induce ocular cell lineages including corneal,
retinal, and neural crest cells, mimicking in vivo eye develop-
ment. This method is considered to be suitable for examining
the relationship between eye development and substrates.
Here, we show how a typical SEAM containing four concentric
cell zones was formed only when hiPSCs were grown on
LN511E8. When cells were expanded on LN211E8 or
LN332E8, on the other hand, the formation of neural crest cells
and epithelial cells (including the corneal epithelium) was
induced, respectively.
Our analysis of the distribution of laminin isoforms in devel-
oping mammalian eyes (Figure 1) suggests that the particular
eye tissue with which a specific laminin isoform is associated
in situ is also the one to which the isoform tends to give rise
in vitro. This raises the possibility of selecting an appropriate iso-(F) Immunostaining for E-cadherin (green) and N-cadherin (red) in cells on LN332E
50 mm (right, magnified panels).
(G) Immunostaining for YAP (green) and PAX6 (red) in hiPSCs on LN332E8 and L
100 mm (lower magnified panels).
(H) hiPSCs on LN332E8 and LN511E8 were fractionated and analyzed by western
(right). C, cytoplasmic fraction; N, nuclear fraction.
(I) Gene expression in hiPSCs on LN332E8 and LN511E8 at day 10 of iPSC cultur
experiments; *p < 0.05.
(J) Schematic of differentiation protocol.
(K) Gene expression in cells. The results are presented as means ± SEM; n = 4 c
(L) Immunostaining for PAX6 (red) in cells. Nuclei, blue. Scale bar: 100 mm.
(M) Gene expression in hiPSCs on LN511E8 with or without verteporfin (VP) (0.3 m
cell samples; ***p < 0.001.form for target hiPSC culture. Consistent with this, we found an
increase in hiPSC-derived corneal epithelial differentiation using
LN332E8, the E8 fragment of laminin-332 expressed specifically
in the stratified epithelium (Figure 2). In our published method of
SEAM formation from hiPSCs grown on LN511E8, it was neces-
sary to pipette away cells other than the epithelial-like cells from
the SEAM to efficiently harvest sufficient numbers of remaining
cells to allow their expansion into an iCEC sheet. Such an inter-
vention is not ideal, however, as it requires some experience,
and the outcome is not always reproducible or favorable.
Culturing hiPSCs on LN332E8, however, eliminates this pipetting
step, and, although the use of this substrate does not induce the
expansion of neural-like cells (Figures S2B–S2D), it appreciably
shortens the culture period for iCEC sheet production. Therefore,
the use of LN332E8 for hiPSC expansion can be recommended
for the fabrication of iCEC sheets.
hPSCs mainly express integrin a6b1 (Miyazaki et al., 2008,
2012), which has a particularly high affinity for laminin-511
but low affinity for laminin-211 (Nishiuchi et al., 2006; Yamada
and Sekiguchi, 2015). hiPSCs differentiated on LN211E8 in
the current experiments were characterized by high expression
of neural crest-related markers and genes encoding Wnt
pathway proteins and their targets (Figure 3). Canonical Wnt
signaling plays a critical role in neural crest induction in vivo
(Garcı´a-Castro et al., 2002) and in vitro (Menendez et al.,
2011). Accordingly, we showed that inhibition of Wnt signaling
decreased neural crest cell differentiation from hiPSCs. Wnt
inhibition during hESC differentiation has been shown to
occur on stiff substrates due to the degradation of b-catenin
via integrin b1-dependent GSK3 and Src activity (Przybyla
et al., 2016). As mentioned above, LN211E8 has the lowest af-
finity for integrin a6b1; thus, it seems likely that substrates with
low affinity for hiPSCs lead to Wnt activation upon initiation of
differentiation.
Our data revealed that YAP also plays an important role in
determining the fates of hPSCs. YAP is an effector of the Hippo
pathway, which is integral for contact inhibition, organ size re-
striction, and mechanotransduction (Dupont et al., 2011; Zhao
et al., 2007). YAP is also involved in the long-term survival and
expansion of hPSCs (Ohgushi et al., 2015), and its inhibition on
soft substrata promotes differentiation into neural lineages
(Dupont, 2016; Musah et al., 2014; Sun et al., 2014). A recent
report also indicated that the extent of YAP inactivation, which
depends on cell density, prompts hPSCs to differentiate into
neuroepithelial cells (Hsiao et al., 2016). Consistent with these8 and LN511E8 at day 3 of differentiation culture. Scale bars: 100 mm (left) and
N511E8 at day 3 of differentiation. Nuclei, blue. Scale bars: 50 mm (upper) and
blotting (left). Nuclear YAP intensity relative to cytoplasmic YAP was quantified
e. Results are shown as means ± SEM; n = 4 cell samples of two independent
ell samples of two independent experiments.
M) at day 3 of differentiation culture. Results are shown as means ± SEM; n = 3
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Figure 5. Actomyosin Contraction and Dense Packing of hiPSCs Grown on LN511E8
(A) Immunostaining for p-MLC (green) in hiPSCs on LN211E8, LN332E8, and LN511E8. Nuclei, blue. Scale bar: 50 mm.
(B) hiPSCs on LN211E8, LN332E8, and LN511E8 analyzed by western blotting.
(C) Schematic of dominant interactions.
(D) Immunostaining for vinculin (green) and phalloidin staining for F-actin (magenta) in hiPSCs on LN511E8 (0.25–2.0 mg$cm2). Nuclei, blue. Scale bar: 50 mm.
(E) Immunostaining for p-MLC (green) in hiPSCs on LN511E8 (0.25–1.0 mg$cm2). Nuclei, blue. Scale bar: 50 mm.
(F) Immunostaining for PAX6 (red) in cells on day 3 of differentiation culture. Nuclei, blue. Scale bar: 100 mm.
(G) Diameter of hiPSC colonies on LN511E8 at different concentrations at day 10. The results are shown as means ± SEM; n = 10 colonies.
(H) The effects of LN511E8.
(I) Schematic of experimental method.
(J) Time-lapse microscopy of hiPSC on LN511E8 with or without blebbistatin (5 mM, Ble). Scale bar: 200 mm.
(K) Representative images of cells. Nuclei, red. Scale bar: 20 mm.
(L) Quantification of cell densities are presented as means ± SEM; n = 9 colonies; ***p < 0.001.
(M) Immunostaining for YAP (green) and PAX6 (red) in cells at the center of hiPSC colonies on LN511E8 at day 3 of differentiation. Nuclei, blue. Scale bars: 100 mm
and 20 mm (magnified panels).
(N) Gene expression in hiPSCs on LN511E8 with or without blebbistatin. Results are shown asmeans ± SEM; n = 7 cell samples of two independent experiments;
*p < 0.05 and **p < 0.01.
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Figure 6. Schematic of Mechanism How the Laminin Isoforms Determine hiPSC Status and Fate
For the affinity of laminin-a6b1, see the report by Nishiuchi et al. (2006).data, we found that neuroectodermal markers, such as PAX6,
are expressed at the centers of high-cell-density hiPSC colonies
grown on LN511E8. In these cells, YAP was excluded from the
nucleus, and its inactivation was most likely due to high cell den-
sity (Figures 4 and S5). We also showed that actomyosin
contraction is involved in the compaction of hiPSC colonies
cultured on LN511E8 and confirmed that MLC phosphorylation,
dense colony packing, and neuroectoderm differentiation
of hiPSCs increased proportionally with the concentration of
LN511E8 coating (Figure 5). This is in line with the findings of
Toh et al. (2015), who reported that activated myosin II, localized
to the periphery of hPSC colonies on Matrigel, is attenuated by
treatment with an anti-a6b1 antibody. Thus, the strength and
frequency of integrin a6b1-substrate binding promotes actomy-
osin contraction at the periphery of hPSC colonies. LN511E8
has a stronger affinity for a6b1 than other substrates, such as
Matrigel (Miyazaki et al., 2012), thus allowing the establishment
of densely packed hPSC colonies achieved via actomyosin
contraction and accompanied by central neuroectodermal
differentiation.
Collectively, the data presented here demonstrate that ecto-
dermal differentiation from hiPSCs can be modulated by the
informed selection of the laminin isoform used as a substrate.
Moreover, we have shown that the binding affinity of substrates
and integrins determines the nature of expanded hiPSC colonies
in terms of cell motility, cell-cell interactions, and cell density,
with the clear involvement of Wnt and YAP signals. The differ-
ence in affinity between differentiated cells and laminin isoforms
thus, we contend, controls the manner in which cells spread and
what proportion become ectodermal cells (Figure 6). This infor-
mation helps elucidate the mechanism of SEAM formation on
LN511E8, which has a unique arrangement consisting of the
neuroectoderm in the central region of the colony and surface
ectoderm at the periphery. It also provides a laminin isoform-
mediated selective differentiation method for hiPSC expansion,
differentiation, and fate.
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Antibodies
Mouse anti-p75 Advanced Targeting Systems Cat#AB-N07; RRID:AB_171797
Goat anti-SOX10 Santa Cruz Biotechnology Cat#sc-17342; RRID:AB_2195374
Rabbit anti-TUBB3 Sigma-Aldrich Cat#T2200; RRID:AB_262133
Mouse anti-E-cadherin R&D Systems Cat#MAB1838; RRID:AB_2076806
Goat anti-VSX2 (CHX10) Santa Cruz Biotechnology Cat#sc-21690; RRID:AB_2216006
Rabbit anti-PAX6 Covance Research Products Inc Cat#PRB-278P; RRID:AB_291612
Mouse anti-MUC16 Abcam Cat#ab697; RRID:AB_305676
Mouse anti-PITX2 Abcam Cat#ab55599; RRID:AB_944836
Rabbit anti-FoxC1 Cell Signaling Technology Cat#8758S
Mouse anti-p63 Santa Cruz Biotechnology Cat#sc-8431; RRID:AB_628091
Rabbit anti-Myosin light chain (phosphor S20) Abcam Cat#ab2480; RRID:AB_303094
Rabbit anti-N-cadherin Abcam Cat#ab76011; AB_1310479
Goat anti-N-cadherin Santa Cruz Biotechnology Cat#sc-31030; RRID:AB_2077520
Mouse anti-YAP Santa Cruz Biotechnology Cat#sc-101199; RRID:AB_1131430
Rabbit anti-NANOG Abcam Cat#ab109250; RRID:AB_10863442
Mouse anti-TRA-1-60 Alexa Fluor 488 conjugate BD Biosciences Cat#560173; RRID:AB_1645379
Donkey anti-mouse IgG Alexa Fluor 488 conjugate Life Technologies Cat#A-21202; RRID:AB_141607
Donkey anti-mouse IgG Alexa Fluor 568 conjugate Life Technologies Cat#A-10037; RRID:AB_2534013
Donkey anti-rabbit IgG Alexa Fluor 488 conjugate Life Technologies Cat#A-21206; RRID:AB_141708
Donkey anti-rabbit IgG Alexa Fluor 594 conjugate Life Technologies Cat#A-21207; RRID:AB_141637
Donkey anti-goat IgG Alexa Fluor 488 conjugate Life Technologies Cat#A-11055; RRID:AB_2534102
Donkey anti-goat IgG Alexa Fluor 568 conjugate Life Technologies Cat#A-11057; RRID:AB_142581
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Rabbit anti-Lamin B1 Abcam Cat#ab16048; RRID:AB_443298
Mouse anti-Vinculin Abcam Cat#ab18058; RRID:AB_444215
Rabbit anti-Vinculin (phosphoTyr822) Sigma-Aldrich Cat#V4889; RRID:AB_477624
Mouse anti-GAPDH Abcam Cat#ab8245; RRID:AB_2107448
Goat anti-Mouse IgG HRP conjugate Abcam Cat#ab6789; RRID:AB_955439
Goat anti-Rabbit IgG HRP conjugate Abcam Cat#ab97051; RRID:AB_10679369
Rat anti-mouse laminin a1 (5B7-H1) (Manabe et al., 2008) N/A
Rat anti-mouse laminin a2 (4H8-2) (Manabe et al., 2008) N/A
Rat anti-mouse laminin a3A (M35-N3-B9) (Manabe et al., 2008) N/A
Rat anti-mouse laminin a4 (M49-N7) (Manabe et al., 2008) N/A
Rat anti-mouse laminin a5 (M5N8-C8) (Manabe et al., 2008) N/A
Donkey Anti-Rat IgG Alexa Fluor 488 Abcam Cat#ab150153; RRID:AB_2737355
Chemicals, Peptides, and Recombinant Proteins
Y-27632 Wako Cat#034-24024
CHIR99021 Sigma-Aldrich Cat#SML1046-5MG
Verteporfin Sigma-Aldrich Cat#SML0534-5MG
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REAGENT or RESOURCE SOURCE IDENTIFIER
Blebbistatin Wako Cat#021-17041
Recombinant E8 fragments of laminin-111 (Taniguchi et al., 2009) N/A
Recombinant E8 fragments of laminin-211 (Taniguchi et al., 2009) N/A
Recombinant E8 fragments of laminin-332 (Miyazaki et al., 2012) N/A
Recombinant E8 fragments of laminin-411 (Ohta et al., 2016) N/A
Recombinant E8 fragments of laminin-511 (Ido et al., 2004, 2007;
Taniguchi et al., 2009)
N/A
iMatrix-511 (LN511E8) Nippi Cat#892012
Recombinant Human KGF Wako Cat#112-00813
Knockout serum replacement (KSR) Life Technologies Cat#10828-028
Sodium pyruvate Life Technologies Cat#11360-070
Non-essential amino acids Life Technologies Cat#11140-050
Penicillin-streptomycin Life Technologies Cat#15140-122
2-Mercaptoethanol Life Technologies Cat#21985-023
Monothioglycerol Wako Cat# 195-15791
B27 supplement Life Technologies Cat#17504-044
4% (wt/vol) Paraformaldehyde (PFA) phosphate
buffer solution
Wako Cat# 163-20145
Normal donkey serum Jackson ImmunoResearch Cat#017-000-121
Hoechst 33342 Wako Cat#346-07951
CytoPainter Phalloidin-iFluor 647 Reagent Abcam Cat#ab176759
Accutase Life Technologies Cat#A11105-01
Mitomycin C (Medicine) Kyowa Hakko Kirin N/A
FBS Life Technologies Cat#12483-020
Rhodamine B Wako Cat#180-00132
Dispase Life Technologies Cat#17105-041
Tissue-Tek OCT compound Sakura finetek Japan Cat#4583
Protease inhibitor cocktail Wako Cat#165-26021
PhosSTOP Sigma-Aldrich Cat#4906845001
5-bromo-4-chloro-3-indolyl phosphate (BCIP)/Nitro
Blue Tetrazolium (NBT)
Sigma-Aldrich Cat#11681451001
Critical Commercial Assays
SuperScript III First-Strand Synthesis System for
qRT-PCR
Life Technologies Cat#18080051
NE-PER Nuclear and Cytoplasmic Extraction
Reagents kit
Thermo Fisher Scientific Cat#78833
Pierce BCA Protein Assay Kit Thermo Fisher Scientific Cat#23227
ECL Prime reagent GE Healthcare Cat#RPN2236
Cell Counting Kit-8 Dojindo Cat#CK04
G-actin/F-actin in vivo Assay Biochem Kit Cytoskelton Cat#BK037
Deposited Data
Microarray data This paper GEO: GSE116591
Experimental Models: Cell Lines
Human: iPS cell line 201B7 RIKEN Bio Resource Center Cat#HPS0063; RRID:CVCL_A324
Human: iPS cell line 1383D2 Center for iPS Cell Research
and Application
N/A
Mouse: NIH 3T3 cell line N/A N/A
Oligonucleotides
Taqman probes are listed in Table S2 Life Technologies Cat#4331182
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Software and Algorithms
GeneSpring GX v14.8 Agilent Technologies RRID:SCR_010972; (https://www.agilent.
com/en/product/cgh-cgh-snp-microarray-
platform/cgh-cgh-snp-microarray-software)
StatLight 2000 Yukms https://www.yukms.com/yukms/jap/html/
StatLight/stalgt_jp.htm
FlowJo Ver v10.1 FlowJo, LLC RRID:SCR_008520; (https://www.flowjo.
com/solutions/flowjo)
SH800 v1-2 SONY https://www.sonybiotechnology.com/us/
Image Lab Software v4.1 Bio-Rad RRID:SCR_014210; (http://www.bio-rad.
com/en-us/sku/1709690-image-lab-
software?ID=1709690)CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Ryuhei
Hayashi (ryuhei.hayashi@ophthal.med.osaka-u.ac.jp).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Pregnant female mice (C57/BL6; 10–16 weeks old; embryonic days [E] 12.5, E15.5, and E18.5) were acquired from SLC Japan (Shi-
zuoka, Japan) for analysis of embryonic eyes. Animal experimentation was approved by the animal ethics committee of Osaka
University.
Cell lines
hiPSC lines 201B7 and 1383D2 were obtained from the RIKEN Bio Resource Center (Tsukuba, Japan) and the Center for iPS Cell
Research and Application (Kyoto University), respectively. hiPSCs were maintained on LN511E8 (0.5 mg$cm2), prepared or pur-
chased from Nippi (iMatrix-511, Tokyo, Japan), along with StemFit medium (Ajinomoto, Tokyo, Japan) in a humidified 5% CO2
and 95% air atmosphere at 37C. All experiments using recombinant DNA in this study were approved and conducted according
to the regulations of the Recombinant DNA Committees of Osaka University. Mouse NIH 3T3 cell line was maintained with 10%
FBS containing D-MEM (Life Technologies, Carlsbad, CA, USA) in a humidified 5% CO2 and 95% air atmosphere at 37C. For
use as feeder cells of colony formation assay, NIH 3T3 cells were treated with 8 mg$ml1 mitomycin C for 2 h.
METHOD DETAILS
Immunohistochemical analyses
Frozen sections generated at E12.5, E15.5, and E18.5 were cut, air-dried, and incubated with TBS containing 5% donkey serum and
0.3% Triton X-100 (Sigma-Aldrich, St. Louis, MO, USA) for 1 h. Sections were then incubated with primary rat antibodies specific to
laminin a1 (5B7-H1), laminin a2 (4H8-2), laminin a3A (M35-N3-B9), laminin a4 (M49-N7), or laminin a5 (M5N8-C8) (Manabe et al.,
2008) for 3 h at room temperature or overnight at 4C, followed by Alexa Fluor-conjugated secondary antibodies (Life Technolo-
gies), and Hoechst 33342 stain (Molecular Probes, Eugene, OR, USA). Stained samples were observed using Axio Observer D1
(Carl Zeiss, Jena, Germany) and LSM 710 (Carl Zeiss) microscopes. Details of the antibodies used are listed in the Mouse Basement
Membrane Bodymap (http://dbarchive.biosciencedbc.jp/archive/matrixome/bm/home.html).
Coating of culture plates
Coating of recombinant laminin E8 fragments (Ido et al., 2004, 2007; Taniguchi et al., 2009) was carried out by adding phosphate
buffered saline (PBS) to culture plates and then adding laminin E8 fragments at a density of 0.5–1.5 mg$cm-2. Plates were incubated
at 37C for at least 1 h.
Ocular cell differentiation
The differentiation protocol used for the induction of hiPSCs into an eye-like SEAMwas based on our previous reports (Hayashi et al.,
2016, 2017) and is illustrated in Figure 1A. hiPSCs were seeded on dishes coated with five different isoforms of LNE8 and cultured ine3 Cell Reports 25, 1668–1679.e1–e5, November 6, 2018
StemFitmedium for 10 days. After hiPSC culture, the growth medium was switched to differentiation medium (DM). After 4 weeks,
the medium was switched to corneal differentiation medium (CDM) and the cells cultured for an additional 4 weeks. At the beginning
of week 9, themediumwas replaced with corneal epitheliummaintenancemedium (CEM), in which the cells were grown for 4 weeks.
Manual pipetting to remove non-epithelial-like cells, as carried out previously (Hayashi et al., 2016, 2017), was not performed in the
present study. An Axio Observer D1 microscope (Carl Zeiss) was used to acquire phase contrast images. The composition of the
medium used is as follows. DM; GMEM (Life Technologies, Carlsbad, CA, USA) supplemented with 10% knockout serum replace-
ment (KSR; Life Technologies), 1 mM sodium pyruvate (Life Technologies), 0.1 mM non-essential amino acids (Life Technologies),
2 mM L-glutamine (Life Technologies), 1% penicillin-streptomycin solution (Life Technologies) and 55 mM 2-mercaptoethanol (Life
Technologies) or monothioglycerol (Wako, Osaka, Japan), CDM; DM and CnT-20 or CnT-PR (without EGF or FGF2) (1:1, CELLnTEC
Advanced Cell Systems, Bern, Switzerland) containing 20 ng$ml1 KGF (Wako), 10 mM Y-27632 (Wako) and 1% penicillin-strepto-
mycin solution, CEM; DMEM/F12 (1:1), (Life Technologies) containing 2% B27 supplement (Life Technologies), 1% penicillin-strep-
tomycin solution, 20 ng$mL1 KGF and 10 mM Y-27632.
Immunofluorescence staining
Cells were fixed with 4% paraformaldehyde (PFA), washed three times with Tris-buffered saline (TBS) (TaKaRa Bio, Shiga, Japan),
and incubated with TBS containing 5% donkey serum and 0.3% Triton X-100 (Sigma-Aldrich) for 1 h to block non-specific reactions.
They were then incubated with various primary antibodies (see Key Resources Table) overnight at 4C and stained with Alexa Fluor-
conjugated secondary antibodies (Life Technologies) and Hoechst 33342 (Wako). Stained samples were observed using an Axio
Observer D1 and LSM710 (Carl Zeiss).
qRT-PCR
Total RNA was extracted from cells using QIAzol reagent (QIAGEN, Venlo, Netherlands). SuperScript III First-Strand Synthesis Sys-
tem for qRT-PCR (Life Technologies) was used to synthesize cDNA. qRT-PCR was performed using an ABI Prism 7500 Fast
Sequence Detection System (Life Technologies), according to the manufacturer’s instructions. The TaqMan MGB used is
described in Table S2.
Flow cytometry and cell sorting
Cells differentiated from hiPSCs were dissociated using Accutase (Life Technologies) and stained with antibodies against SSEA-4
(330406, BioLegend, San Diego, CA, USA), CD104 (ITGB4; 624024, BD Biosciences, Franklin Lakes, NJ, USA), and CD200
(624052, BD Biosciences), as well as against CD271 (p75; 557196, BD Biosciences) and CD40d (ITGA4; 304308, BioLegend) as neu-
ral crest markers, for 30–60 min on ice. FACS Verse (BD Biosciences) or SH800 (Sony, Tokyo, Japan) was used for the analysis, and
cell sorting was performed using an SH800 device. Data were analyzed using Sony SH800 and FlowJo software (TreeStar, San
Carlos, CA, USA).
Colony formation assay
Sorted cells were seeded onto MMC-treated NIH 3T3 feeder cells at a density of 1000–2000 cells per 12-well plate and cultured in
CMM (corneal epithelium maturation medium; KCM medium containing 20 ng$mL1 KGF and 10 mM Y-27632) for 7–14 days. The
colonies were fixed with 10% formaldehyde in neutral buffer solution, stained with rhodamine B (Wako), and counted to calculate
the colony-forming efficiency.
Fabrication and harvesting of hiPSC-derived iCEC sheets
Preparation of hiPSC-derived iCEC sheets was performed based on a previously described protocol (Hayashi et al., 2016, 2017).
iCECs obtained by FACS sorting were seeded onto 12-well plate or cell culture insert (BD Falcon, Bedford, MA, USA) and cultured
in CEMuntil confluence. For harvesting, iCEC sheets were treatedwith 2.4 units$mL1 Dispase (Life Technologies) at 37C for 10min,
removed, and embedded in Tissue-Tek OCT compound (Sakura Finetek, Tokyo, Japan) and frozen. When cell culture insert is used,
cell sheet on membrane was cut out and embedded.
Microarray analysis
Total RNA was isolated from differentiated hiPSCs (clone 201B7) grown on laminin isoforms on day 3 using an RNeasy Plus micro kit
(QIAGEN). Microarray analysis using Sure Print G3 human 83 60K slides (Agilent Technologies, Palo Alto, CA, USA) was performed
by TaKaRa Bio. The raw intensity values were imported into GeneSpring GX software (Agilent Technologies). The values were log2-
transformed to themedian of all samples and normalized to the 75th percentile. Principal component analysis, hierarchical clustering
analysis, and pathway analysis using Wikipathways were performed using GeneSpring GX.
Time-lapse recording
For time-lapse recording, hiPSCs were visualized using an IncuCyte Live-Cell Imaging System (ESSEN BioScience Inc., Ann Arbor,
MI, USA).Cell Reports 25, 1668–1679.e1–e5, November 6, 2018 e4
Quantification of hiPSC-derived colony diameters
The diameters of hiPSC colonies were measured using an EVOS FL Auto microscope and the accompanying software (Life
Technologies).
Quantification of cell density within hiPSC colonies
Images of cells stained with Hoechst 33342 were acquired using an Axio Observer D1 microscope. The numbers of cells within a
100-mm square were manually counted from the images and converted into cells∙mm2.
Cell fractionation and western blotting
Cells were lysed in RIPA buffer (Thermo Fisher Scientific, Waltham, MA, USA) containing protease inhibitor cocktail (Wako) and
phosSTOP (Roche, Basel, Switzerland) according to the manufacturer’s protocol. Nuclear and cytoplasmic fractions were prepared
using the NE-PER Nuclear and Cytoplasmic Extraction Reagents kit (Thermo Fisher Scientific) according to the manufacturer’s pro-
tocol. Protein concentrations were determined using a Pierce BCA Protein Assay Kit (Thermo Fisher Scientific). Equal amounts of
protein were subjected to SDS-PAGE using NuPAGE 4%–12% gradient Bis-Tris gels, and transferred to polyvinylidene fluoride
membranes using an iBlot system (Invitrogen, Waltham, MA, USA). The membrane was incubated with antibodies against YAP
(sc-101199, 1:200, Santa Cruz Biotechnology), lamin B1 (ab16048, 1:10,000, Abcam, Cambridge, UK), p-MLC (ab2480, 1:1000;
Abcam), p-vinculin (V4889, 1:1,000; Sigma-Aldrich), vinculin (ab18058; Abcam), or GAPDH (ab8245, 1:5,000; Abcam) for 3 h at
room temperature or overnight at 4C. After washing, membranes were incubated with horseradish peroxidase-conjugated anti-
mouse IgG (ab6789, 1:5,000; Abcam) or anti-rabbit IgG (ab97051, 1:5,000; Abcam) secondary antibodies for 1 h at room tempera-
ture. Proteins were detected with ECL Prime reagent (GE Healthcare, Little Chalfont, UK), scanned, and analyzed with a ChemiDoc
XRS+ imaging system and Image Lab software (Bio-Rad, Hercules, CA, USA).
Cell viability assay
Cell viability was measured using a Cell Counting Kit-8 (Dojindo, Kumamoto, Japan), according to the manufacturer’s instructions.
Absorbance was measured in a multilabel counter (ARVO MX, Perkin Elimer, MA, USA).
Alkaline phosphatase staining
Cells were washed with alkaline phosphatase buffer [100 mM Tris-HCl (pH 9.5) 100 mM NaCl, 5 mM MgCl2] and stained with
5-bromo-4-chloro-3-indolyl phosphate/Nitro Blue Tetrazolium (BCIT/NBT) (Sigma-Aldrich) for 10 min. Cells were then rinsed twice
with PBS and fixed with 4% PFA for 30 min and washed with deionized water. Observations were performed with an EVOS FL
Auto system (Life Technologies).
Isolation of the cells in zone 1 of the SEAM
Cells from the central region on the colony (i.e., zone 1) were collected via pipetting. The cells were dissociated with Accutase for 1 h.
Assessment of F-actin/G-actin ratio
The status of F-actin/G-actin in hiPSCs grown on isoforms LN332E8 and LN511E8 on day 10 of culture was analyzed using a G-actin/
F-actin in vivo assay kit (Cytoskelton, Inc., Denver, CO, USA), based on the manufacturer’s protocol.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis
Statistical details of experiments described in corresponding figure legends. Data are represented as the mean ± standard error for
each group. Statistical significance was analyzed via Student’s t test, Tukey–Kramer test, Wilcoxon rank sum test, and Steel–Dwass
test using StatLight 2000 software (Yukms Co. Ltd., Tokyo, Japan). All statistical analyses were conducted with a significance level of
a = 0.05 (P < 0.05).
DATA AND SOFTWARE AVAILABILITY
Microarray raw intensity values were imported into GeneSpring GX software ver 14.8 (Agilent Technologies). The accession number
for the microarray data reported in this paper is Gene Expression Omnibus: GSE116591.e5 Cell Reports 25, 1668–1679.e1–e5, November 6, 2018
